William B. Schultz focuses on complex regulatory issues and provides strategic advice to companies and public interest organizations. He represents providers and consumers before the U.S. Department of Health and Human Services (where he served as general counsel), other federal agencies, and the courts.
Bill also assists generic drug companies, nonprofit organizations and other clients before the Food and Drug Administration, where he served as Deputy Commissioner for Policy.
As general counsel at HHS from 2011 to 2016, Bill served as counsel to two HHS secretaries on all legal matters and managed an office of 500 lawyers across eight offices, covering 10 regions across the country. HHS administers $1 trillion per year in federal programs, including Medicare, Medicaid, the Affordable Care Act, the FDA, the National Institutes of Health, and the Centers for Disease Control. The office of general counsel is responsible for all litigation where HHS is a party, ensuring regulations and policy decisions are consistent with the law, reviewing legal issues involving appropriations, and ensuring ethical rules are followed.
Prior to joining HHS, Bill was a partner at Zuckerman Spaeder and represented nonprofit organizations, state and local governments, individuals, generic drug companies and small biotechnology companies.
From 1999 to 2000, Bill was deputy assistant attorney general at the U.S. Department of Justice, where he was responsible for overseeing all civil division appellate litigation and the department’s tobacco litigation team.
From 1994 to 1999, Bill was deputy commissioner for policy for the FDA, where he was the principal advisor to the Commissioner on all significant policy issues and was responsible for development and management of all regulations.From 1989 to 1994, Bill was the counsel to the Subcommittee on Health and the Environment (Rep. Henry A. Waxman, chairman), Committee on Energy and Commerce, U.S. House of Representatives, where he worked on health care, FDA, tobacco and trade legislation.